Benicar (olmesartan medoxomil) NDC 0713-0862

NDC codes

FDA NDC Directory

Product NDC (as listed)0713-0862Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00713-0862Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0713-0862-30	00713086230	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0862-30)Marketed from Sep 1, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Benicar
Generic name (nonproprietary): olmesartan medoxomil
Active ingredients: Olmesartan medoxomil — 40 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Cosette Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021286
Marketing start: Sep 1, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin 2 Receptor Antagonists (Mechanism)
Identifiers: Product ID 0713-0862_00494313-514a-b3b5-e063-6294a90a5ad5SPL ID 00494313-514a-b3b5-e063-6294a90a5ad5SPL set ID 5b6f8a18-8f8a-4521-81c3-3a39c73c6646RxCUI 349373, 349401, 349405, 352199, 352200, 352201UNII 6M97XTV3HDUPC 0307130861304, 0307130862301, 0307130860307
Pharmacologic class: Angiotensin 2 Receptor Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400713086230 followed by a unit qualifier and the quantity

Package 00713-0862-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 12, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Benicar is indicated for the treatment of hypertension in adults and children six years of age and older, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which this drug principally belongs. There are no controlled trials demonstrating risk reduction with Benicar. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy,…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 021286

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 021286
Product	Strength	Form · route	Labeler	Product NDC
Benicarolmesartan medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	Cosette Pharmaceuticals, Inc.	0713-0940
Benicarolmesartan medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, Film coatedOral	Cosette Pharmaceuticals, Inc.	0713-0941
Benicarolmesartan medoxomil	Olmesartan medoxomil 5 mg/1	Tablet, Film coatedOral	Cosette Pharmaceuticals, Inc.	0713-0860
Benicarolmesartan medoxomil	Olmesartan medoxomil 40 mg/1	Tablet, Film coatedOral	Cosette Pharmaceuticals, Inc.	0713-0942
Benicarolmesartan medoxomil	Olmesartan medoxomil 20 mg/1	Tablet, Film coatedOral	Cosette Pharmaceuticals, Inc.	0713-0861